Kananda Barrons

To invest is not to bet, you can try but maybe you'll cry. My opinion is not your decision, choose an option at your own risk.

[Kananda Barrons @KanandaBarrons]

$AGEN At least data is positive, but as usual market does not recognize its real value.
There was a time for innovation, now is the time to react & put things right:
*It's actually a race against time, until @Agenus_Bio sale or similar options are on the table. @garo_armen

[Seeking Alpha Market Currents @MarketCurrents]

$AGEN - Agenus stock up 7% on positive data for colorectal cancer drugs https://t.co/bk5UOjGqBE

[Kananda Barrons @KanandaBarrons]

$AGEN Agree with the substance:
Now is the time to act, before we reach the point of no return.
"ACTING IN DEFENSE OF SHAREHOLDERS INTEREST WE ARE EXPLORING A SALE OF THE COMPANY, because public markets don't recognize its real value." @Agenus_Bio @garo_armen @jbuell01

[R_HUNTER @RHUNTER34290820]

$AGEN CEO @garo_armen & Pres. @jbuell01, you both are responsibles for @Agenus_Bio debacle. It takes only a minute to say the magical words: "ACTING IN DEFENSE OF SHAREHOLDERS INTEREST WE ARE EXPLORING A SALE OF THE COMPANY, because public markets don't recognize its real value."

[Kananda Barrons @KanandaBarrons]

$ONON $LYV Younger generations are increasingly spending their money with these companies:
*Both companies are demonstrating the fundamental business growth to become long-term winners.

https://t.co/ABARo1iq9z

[Kananda Barrons @KanandaBarrons]

$ALB $LTHM Janet Yellen spoke in front of one-ton bags of lithium hydroxide at a Livent warehouse & said the "battery belt"showed the administration's strategy is working and contributing to current low rates of unemployment and ongoing economic growth.
https://t.co/N93XahB0GD

[Kananda Barrons @KanandaBarrons]

$IMGN Today is a day that Longs commemorate with celebration!
@abbvie to Acquire @ImmunoGenInc for $31.26/SH:
#BULLISH >650% Profits from the exact point where my trendline is crossed!
I hope $AGEN @Agenus_Bio ends up going the same way to accelerate its BOT/BAL program.

[Kananda Barrons @KanandaBarrons]

$ONON @on_running opens flagship store in #Paris as the brand looks to go global:
*Shares of $ONON have recaptured momentum over the last 6 weeks and are showing a year-to-date gain of over 60%.
https://t.co/nBZXxdI7vC

[Kananda Barrons @KanandaBarrons]

$AGEN I'm glad its hush-hush policy had been reconsidered:
Dr.@garo_armen in CC: https://t.co/4o9rZ6xVxg
Having said that, corporate transaction with a large pharma should be an agreement to sell @Agenus_Bio, we are not in a situation to continue to fund the Company with juggling

[Kananda Barrons @KanandaBarrons]

$AGEN Like the comic strips in the newspaper @Telegraph @thetimes!
This would be comical if it were not so tragic for shareholders: Obviously, a wisest and promptest decision is urgently needed but it's extremely difficult to understand its hush-hush policy depriving us of CC.

[Kananda Barrons @KanandaBarrons]

$AGEN The value of @Agenus_Bio adjuvant QS-21 STIMULON:
The Global Therapeutic Vaccines Market, estimated at USD 9.09 billion in 2023, is projected to reach USD 11.98 billion by 2028, boasting a Compound Annual Growth Rate (CAGR) of 5.68%.
https://t.co/zhObC9hK5a

[Kananda Barrons @KanandaBarrons]

$AGEN and $GSK positive PH 3 trial results for its RSV vaccine candidate containing QS-21 STIMULON™. @Agenus_Bio subsidiary, @saponiQx, is pursuing scalable, sustainable, and cost-effective production of adjuvants, including QS-21 STIMULON.

[Kananda Barrons @KanandaBarrons]

$AGEN Like the comic strips in the newspaper @Telegraph @thetimes!
This would be comical if it were not so tragic for shareholders: Obviously, a wisest and promptest decision is urgently needed but it's extremely difficult to understand its hush-hush policy depriving us of CC.

[R_HUNTER @RHUNTER34290820]

$AGEN CEO @garo_armen & Pres. @jbuell01 Today is Halloween for everybody, but every day is HELL-AGEN for @Agenus_Bio shareholders. It's time for a trick & treat, to awaken from an endless nightmare mismanagement that has led to an astonishing and terrifying value destruction.

[Kananda Barrons @KanandaBarrons]

$AGEN #ESMO2023 Zoom Webinar Recording:
https://t.co/Pab4ObmrcH

[Kananda Barrons @KanandaBarrons]

$AGEN Indeed, it's time to make important decisions @RHUNTER34290820, and the sale of Agenus is the opportunity we are still waiting for, unless otherwise decided by the Company in the best interests of the Shareholders.

[R_HUNTER @RHUNTER34290820]

$AGEN CEO @garo_armen & Pres. @jbuell01 it's UNACCEPTABLE to remain in @Agenus_Bio office and keep silent hidden under a rock while the equity is endlessly bleeding to new all-time lows. It's time to make the right decision once and for all, announcing the SALE OF THE COMPANY!!!.

[Kananda Barrons @KanandaBarrons]

$GILD @GileadSciences Now the time has come to move ahead for purchasing decisions on @Agenus_Bio $AGEN.

[BIOTECH @_B_I_O_T_E_C_H_]

Is $AGEN Agenus the Most Under the Radar Biotech in I/O?
Initiate at Buy and $12 PT
$BMY $INCY $GILD $MRK

[Kananda Barrons @KanandaBarrons]

$BMY Today announced:
-Definitive merger agreement to acquire @Mirati $MRTX for $58.00/SH: $4.8 billion.
-@Mirati stockholders'll also receive one non-tradeable CVR/Mirati SH up to $12 per share in cash.
$AGEN @Agenus_Bio stockholders still waiting for similar opportunity!

[Bristol Myers Squibb @bmsnews]

We're excited to announce an agreement to acquire @Mirati to support the growth of our diversified oncology portfolio and accelerate development of potential breakthrough medicines for cancer patients. For more information & cautionary statements: https://t.co/MQH0VdfR3F

[Kananda Barrons @KanandaBarrons]

$AGEN @Agenus_Bio Another milestone towards an ever closer first regulatory submission for the botensilimab/balstilimab combination in colorectal cancer & global accelerated approval strategies for CRC.

[Forbes @Forbes]

New Drug Combo Shows Promising Results Against Early Stages Of Colorectal Cancer https://t.co/fe6XbjaHGG by @TheAlexKnapp

[Kananda Barrons @KanandaBarrons]

$AGEN @Agenus_Bio #ESMO GI Data Botensilimab/Balstilimab Combination Achieves Unprecedented Survival in Advanced #ColorectalCancer:
*ORR 23% + DCR 80% vs. 3% Standard of
care
Agenus is planning to submit its first BLA to the #FDA
https://t.co/kQvm28wUfY

[Kananda Barrons @KanandaBarrons]

$FREY #Batterytechnology for scaling up of sustainable battery solutions across #Europe, #NorthAmerica, and beyond
https://t.co/Am2bk4RnCS
Celebrating for reopening position this Wednesday at the exact point where my #bullish trendline is crossed:
+20% #Profits since that date

[Kananda Barrons @KanandaBarrons]

$AGEN As I indicated yesterday, Agenus' Investigational #Cancer Combo Therapy merits closer attention by #stockmarkets:
*Substantial improvement in efficacy in metastatic tumors was reinforced yesterday by @Agenus_Bio with 33% ORR #OvarianCancer vs. existing therapies only 3-10%

[Agenus @Agenus_Bio]

Our CMO @ODayMD, reflects on #ColorectalCancerAwarenessMonth, recent #news for #botensilimab in #OvarianCancer, and our mission to develop an arsenal of #immunotherapy treatments.

#ColorectalCancer #oncology

https://t.co/zqMlgiFXgK

[Kananda Barrons @KanandaBarrons]

$AGEN If existing therapies reported only 3-10% ORR vs. 33% @Agenus_Bio ORR:
*Why big drug companies don't separate competing offers for our PD-(L)1 + CTLA-4 combinations?
This is the great paradox!

https://t.co/oPK40vyKlX

[Kananda Barrons @KanandaBarrons]

$CROX Today announced its fourth #quarterlyresults and Record Annual Revenues of $3.6 Billion, Growing 54% Over 2021:
I'm celebrating for having reopened position at the end of July 2022 at the exact point where my #bullish trendline is crossed:
+145% #Profits since that date.

[Kananda Barrons @KanandaBarrons]

$AGEN and $GSK positive PH 3 trial results for its RSV vaccine candidate containing QS-21 STIMULON™. @Agenus_Bio subsidiary, @saponiQx, is pursuing scalable, sustainable, and cost-effective production of adjuvants, including QS-21 STIMULON.

[Agenus @Agenus_Bio]

Congrats to our partner @GSK on publication of the positive PH 3 trial results for its RSV vaccine candidate containing QS-21 STIMULON™. Agenus’ subsidiary, @saponiQx, is pursuing scalable, sustainable, and cost-effective production of adjuvants, including QS-21 STIMULON.